Compass Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -6.32 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
1.38 | 4.82 | -71.44% |
|
|
| P/FCF |
|
-7.81 | 61 | -112.8% |
|
|
| Ev/Ebitda |
|
-3.76 | -22.15 | -83.05% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-4.48 | 68.78 | -106.51% |
|
|
| E/P |
|
-0.1338 | 0.0178 | -852.8% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
-28.61 | 9.61 | -397.64% |
|
|
| ROA |
|
-27.09 | 0.3443 | -7968.43% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-33.91 | 15.35 | -320.88% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0358 | -3.68 | -99.03% | -0.0644 | -44.5% |
| Nеt Debt/Ebitda |
|
0.4641 | -3.44 | -113.5% |
|
|
| Debt/Ratio |
|
0.011 | 0.1985 | -94.43% |
|
|
| Debt/Equity |
|
1.08 | 1.66 | -34.84% |
|
|
| Debt/Net Income |
|
-0.0408 | 10.32 | -100.4% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
55.36 | -54.68 | -201.24% | ||
| Growth impulse Net Income in 5 years |
|
22.46 | -58.33 | -138.51% | ||
| Growth impulse FCF in 5 years |
|
26.24 | -49.48 | -153.03% | ||
| Growth impulse EPS in 5 years |
|
-49.82 | -32.41 | 53.72% |
IP Score
3.22/10
